Navigation Links
New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis

partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at www.roche.com.

All trademarks used or mentioned in this release are protected by law.

Further information - Roche & Autoimmune diseases: www.roche.com/med_events_mb1106

References: (1) TOWARD refers to Tocilizumab in cOmbination With traditional DMARD therapy (2) The ACR response is a standard assessment used to measure patients' responses to anti-rheumatic therapies, devised by the American College of Rheumatology (ACR). It requires a patient to have a defined percentage reduction in a number of symptoms and measures of their disease. For example, a 20 or 50% level of reduction (the percentage of reduction of RA symptoms) is represented as ACR20, ACR50 or ACR70. An ACR70 response is exceptional for existing treatments and represents a significant improvement in a patient's condition. (3) OPTION refers to the TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders

Roche Group Media Office Phone: +41 61 688 8888 / e-mail: basel.mediaoffice@roche.com - Daniel Piller (Head of Roche Group Media Office) - Katja Prowald (Head of Science Communications) - Martina Rupp - Baschi Dürr - Claudia Schmitt

F. Hoffmann-La Roche Ltd Corporate Communications Grenzacherstrasse 124 4070 Basel, Switzerland

Phone: +41 61 68 88888 Fax: +41 61 68 82775 mailto:basel.mediaoffice@roche.com www.roche.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients
4. Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases
5. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
6. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
7. New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
10. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

Post Your Comments:
(Date:11/23/2009)...tlinker.comannouncesthatanewmarketresearchreportis...ms&Equipment-AGlobalMarketPerspective ,, ...n-Systems--Equipment---A-Global-Market-Perspective...utm_campaign=prnewswire ,, Steamsterilizati...ure.Steamsterilizationmarketisstableduetoregulator...
(Date:11/23/2009)...tlinker.comannouncesthatanewmarketresearchreportis...les-AWorldMarketReview ,, http://www.reportl...d-Market-Review.html#utm_source=prnewswire&utm...lobalgeneralanesthesiadisposablesmarketischaracter...lerisewitnessedingeneralsurgicalprocedures,growing...
(Date:11/23/2009)...--LightSciencesOncology,Inc.(LSO)todayannouncedthe...oanewlycreatedseatonitsboardofdirectors.Mr.Seddigh...anies,includingElekta,tomarketleadership. ,, "T...hinbusinessdevelopmenttotheboard,"saidLSO,sChairma...cancer-therapybusinessdevelopment.Hehasoverseenthe...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2UCLA scientists make paralyzed rats walk again after spinal cord injury 9985 1UCLA scientists make paralyzed rats walk again after spinal cord injury 9985 2Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 1Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 2Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 3Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 4Optics made to measure 14158 1Optics made to measure 14158 2Optics made to measure 14158 3
..., April 15 Cardium Therapeutics,(Amex: CXM ) and...today that,positive findings from a preclinical st...arly rapid hyperthermia (cooling) for the potentia...attack), has been published,online by BioMed Centr...l,10, 2008)., (Photo: http://www.newscom.com/cgi...
...leoside-Sparing Regimen Designed to Avoid Risk of ...ass of HIV Drugs, KENILWORTH, N.J., April 15 Sch...nced that it has initiated a Phase II,clinical stu...onist, for,use in first-line therapy of adult trea...us only. Vicriviroc is a next-generation HIV entry...
Other Medicine Technology:Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 2Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 3Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 4Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 5Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 6Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 7Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 8Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 9Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 10Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 11Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 12Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients 2Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients 3Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients 4Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients 5Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients 6
(Date:11/23/2009)...3/PRNewswire/--XiotechCorporationtodayannouncedtha...TM)7000storagesystem,poweredbyIntelligentStorageEl...orageneeds,enablefuturegrowthanddeliversignificant...enter. ,, MasonGeneral,locatedinShelton,Wash.,w...,s"MostWired-Rural"hospitalsin2008and2009foritssup...
(Date:11/23/2009)...lants need longer-term support than most friends, ..., according to a study of 160 patients published i...dvanced Nursing . , Researchers surveyed 55 ...r, together with 105 who had had surgery in the la... Center in Tennessee, USA. They wanted to see if t...
(Date:11/23/2009)...ically modified to produce bacterial proteins that..., have been planted on more than 200 million hecta...amed after the bacterium Bacillus thuringiensis ,..., allowing farmers to save money and lessen enviro... However, since insects can evolve resistance to ...
(Date:11/23/2009)...t explain why more blacks die than whites, study f...) -- Body weight and co-existing health problems d...lower survival rates than whites, U.S. researchers...ve lower survival rates than whites for nearly all...ave explored a variety factors, such as difference...
(Date:11/23/2009)...nn.,Nov.23/PRNewswire/--HealthLeaders-InterStudy,a...ortsthatself-insuredmembercompaniesthatarepartofMi...ggregatehealthcare-costdecreaseof1.5percentperheal...high-performanceprovidernetwork.Accordingtothe Mil...nsuredmembercompaniessaved$44millioninhealthcareco...
Breaking Medicine News(10 mins):Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Weight May Not Drive Racial Disparities in Colon Cancer 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2
...nc. (Nasdaq:,ICAD), an industry-leading provider o... early identification of cancer, today announced t... with the private equity,firm, Welsh, Carson, Ande...mber of directors to eight. Mr. Ecock, age,46, bri...
... with New President, Congress on,Public-Private Ef...h Care,Payment Systems to Emphasize Wellness, Evid... of chief,executives from many of the nation,s lea...th care gap, between the status,quo and the ,healt...
...] Scientists at the Swedish medical university Kar...n that a receptor called ALK7 plays important role... as the release of insulin from beta-cells in the ...moving the ALK7 receptor improves insulin release ...
...ess Releases its 2007 Claims Review from,Leading I...ion Data,, PORTLAND, Maine, May 13 Data from the...d today by the Council for,Disability Awareness (C...ng-term disabilities has grown four times,the grow...
...-PRNewswire-FirstCall/ -- China Sky One,Medical, I...C Bulletin,Board: CSKI), a leading fully integrate...e-counter drugs in the People,s Republic of China,...aldorf Astoria in New York City., Mr. Yanqing Liu...
... Promising results from a team of NewYork-Presbyte...an-scientists show that gene therapy is both safe ... disease, or Late Infantile Neuronal Ceroid Lipofu...rial found that the procedure -- which involves in...
Other Medicine News:Health News:iCAD, Inc. Appoints Anthony F. Ecock to Board of Directors 2Health News:CEOs From Multiple Health Industries Announce Consensus Plan to Reform U.S. Health Care 2Health News:CEOs From Multiple Health Industries Announce Consensus Plan to Reform U.S. Health Care 3Health News:Novel mechanisms controlling insulin release and fat deposition discovered 2Health News:New Data Shows Continued Growth of Long-Term Disability Claims and Decline in Social Security Disability Insurance Applications Approval Rate 2Health News:New Data Shows Continued Growth of Long-Term Disability Claims and Decline in Social Security Disability Insurance Applications Approval Rate 3Health News:China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference 2Health News:NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: